Chronic Recurrent Multifocal Osteomyelitis Overview
Learn About Chronic Recurrent Multifocal Osteomyelitis
- Chronic recurrent multifocal osteomyelitis
- CMO
- CNO/CRMO
- CRMO
- Chronic multifocal osteomyelitis
- Chronic nonbacterial osteomyelitis/Chronic recurrent multifocal osteomyelitis
- Multifocal osteomyelitis, chronic
Christian Hedrich practices in Liverpool, United Kingdom. Mr. Hedrich is rated as an Elite expert by MediFind in the treatment of Chronic Recurrent Multifocal Osteomyelitis. His top areas of expertise are Chronic Recurrent Multifocal Osteomyelitis, Osteomyelitis, Osteomyelitis in Children, and Systemic Lupus Erythematosus (SLE).
Ronald Laxer practices in Toronto, Canada. Mr. Laxer is rated as an Elite expert by MediFind in the treatment of Chronic Recurrent Multifocal Osteomyelitis. His top areas of expertise are Chronic Recurrent Multifocal Osteomyelitis, Localized Scleroderma, Osteomyelitis, Osteomyelitis in Children, and Tissue Biopsy.
Hermann Girschick practices in Friedrichshain Bezirk, Germany. Mr. Girschick is rated as an Elite expert by MediFind in the treatment of Chronic Recurrent Multifocal Osteomyelitis. His top areas of expertise are Osteomyelitis, Chronic Recurrent Multifocal Osteomyelitis, Osteomyelitis in Children, and Hypophosphatasia (HPP).
Summary: CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily as possible to help advance treatments and cures for rare diseases. The CoRDS team works with patient advocacy groups, in...
Summary: The objective of the study is to establish a prospective disease registry for chronic recurrent multifocal osteomyelitis (CRMO)/chronic nonbacterial osteomyelitis (CNO) in order to investigate the natural history of the disease and the responses of patients to different clinical managements over 10 years.
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center